Health ❯ Patient Care

Treatment Options

Medication Innovative Therapies Oral Medications Clinical Trials Symptom Management Food Allergy Treatments Chronic Pain Artificial Tears Gene Therapy Antibiotic Treatment

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

Researchers call for larger, longer studies to confirm durability and safety for patients who cannot tolerate CPAP.

Early-Onset Colorectal Cancer Surges, Prompting Fresh Calls for Screening at 45

Ahead of World Glaucoma Day, Experts Urge Annual Eye Exams and Reject Cannabis as Treatment

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Emma Willis Reveals Lifelong Heart Defect as She Backs BHF Awareness Drive

Study Ties NT‑proBNP Blood Test to Complication Risk in Hypertrophic Cardiomyopathy

Tohoku University Team to Launch Investigator-Led Trial of New Mitochondrial Disease Drug in December

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

CHMP Backs Brinsupri as First EU Therapy for Non‑Cystic Fibrosis Bronchiectasis

Study Finds Higher Parkinson's Risk Among People With Restless Leg Syndrome

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Gene Therapy Slows Huntington’s Progression by 75% in Three-Year Trial

EU Panel Backs Tezspire for Chronic Rhinosinusitis With Nasal Polyps

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing

Study Finds Most Heart Attacks in Younger Women Are Not From Blocked Arteries

BioNTech Breast Cancer ADC Meets Phase 3 Goal in China Interim Analysis

Measles Resurgence Triggers New Alerts in Australia as Alabama Confirms First Case Since 2002

Key Early Symptoms Identified for Larynx and Nasal Cancers in Germany